Max Healthcare Institute Ltd. (MAXHEALTH) 52 Week Low Streak: Why MAXHEALTH is still near its yearly low
- October 1, 2026
- Posted by: Chaitanya Auti
- Category: News
Max Healthcare Institute Ltd. (MAXHEALTH) has now traded within 2% of its 52-week low for its second straight session, with the stock showing a cumulative decline of 1.78% across that streak. In the latest session, it touched a low of Rs 797 and was last trading at Rs 814.55. Univest data confirms the repeated near-low pattern, but it does not establish a company-specific cause for the continued weakness.
Against the previous close of Rs 820, the stock was down Rs 5.45, or 0.66%, after opening at Rs 810.05 and touching a high of Rs 816. Its market capitalisation stood at Rs 80,716.62 crore. For readers, this is more than a one-day move: the repeated proximity to the 52-week low points to a broader stretch of weakness that deserves context through fundamentals, sector positioning and peer comparison.
Max Healthcare Institute Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 814.55 |
| Previous Close | Rs 820 |
| Today's Move | Rs -5.45 (-0.66%) |
| Open | Rs 810.05 |
| High | Rs 816 |
| Low | Rs 797 |
| Market Capitalisation | Rs 80,716.62 crore |
Max Healthcare Institute Ltd. (MAXHEALTH) traded at Rs 814.55 versus the previous close of Rs 820, a fall of 0.66%. The stock opened at Rs 810.05, reached a high of Rs 816, touched a low of Rs 797.
MAXHEALTH share price today stayed under pressure as the stock traded below the previous close of Rs 820 and remained close to its intraday low for much of the move. The current price of Rs 814.55 marked a decline of Rs 5.45, or 0.66%, versus the previous session’s official level. It opened at Rs 810.05, moved up to Rs 816 and then slipped to a low of Rs 797, keeping the day’s range fairly narrow around the lower end. That positioning matters because the stock is not just weak on one print; it is holding near the same price zone for a second straight session.
The market capitalisation of Rs 80,716.62 crore keeps MAXHEALTH among the larger listed names in the hospital and healthcare services space, but size alone does not prevent a stock from staying near a yearly low. For investors tracking MAXHEALTH share price today, the key point is that the repeated near-low pattern is now more meaningful than a single-day dip. It suggests persistent caution around the stock price, even though the latest data does not explain why that caution has continued.
What the Repeated 52-Week Lows Show
The extended 52-week low streak is the main story here. MAXHEALTH has spent two consecutive sessions trading within 2% of its one-year trough, and the cumulative decline across that run stands at 1.78%. That is a useful distinction because a one-day slip can be temporary, while a multi-session pattern shows that the share price has remained under repeated pressure in the same lower band. The latest Univest data confirms the pattern, but it does not identify a company-specific trigger.
For market readers, the repeated low-zone trading usually shifts attention away from the day’s percentage change and toward the broader stock performance trend. It also helps explain why this remains a stock news item even without a fresh corporate announcement. When a share keeps returning to the same lower region, investors tend to watch whether the move becomes prolonged, whether valuation changes materially and whether any fresh company news alters sentiment.
Max Healthcare Institute Ltd. (MAXHEALTH) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 80,716.62 crore |
| P/E Ratio | 54.78x |
| P/B Ratio | 7.3x |
| ROE | 14.53% |
| ROCE | 14.97% |
| EPS | Rs 14.97 |
| Book Value Per Share | Rs 112.27 |
| Dividend Yield | 0.24% |
Max Healthcare Institute Ltd. (MAXHEALTH) fundamental metrics show P/E 54.78x, P/B 7.3x, ROE 14.53%, ROCE 14.97%. These figures provide context only and are not a buy or sell signal.
Max Healthcare Institute Ltd. has a market capitalisation of Rs 80,716.62 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 54.78x, P/B at 7.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.53% and ROCE of 14.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 14.97, book value per share of Rs 112.27, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.84x, median ROE of 12.95%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 54.78x |
| Benchmark Median P/E | 31.84x |
| Benchmark Average P/E | 80.32x |
| Benchmark P/E Range | 0x to 1,528.53x |
| Company P/B Ratio | 7.3x |
| Benchmark Median P/B | 3.57x |
| Company ROE | 14.53% |
| Benchmark Median ROE | 12.95% |
| Company ROCE | 14.97% |
| Benchmark Median ROCE | 15.83% |
| Company Market Capitalisation | Rs 80,716.62 crore |
| Benchmark Median Market Cap | Rs 505.79 crore |
Max Healthcare Institute Ltd. (MAXHEALTH) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Max Healthcare Institute Ltd. (MAXHEALTH) has a P/E ratio of 54.78x, which is above the benchmark median of 31.84x, a difference of +72.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Max Healthcare Institute Ltd. (MAXHEALTH) has a ROE of 14.53%, which is above the benchmark median of 12.95%, a difference of +12.2%. Max Healthcare Institute Ltd. (MAXHEALTH) has a ROCE of 14.97%, which is below the benchmark median of 15.83%, a difference of -5.43%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 82,855.61 | 92.4 | 4.97 | 12.95 | 13.93 |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP | 1,10,757.32 | 52.33 | 11.29 | 23.54 | 21.73 |
| Aster DM Healthcare Ltd. | ASTERDM | 58,157.99 | 177.79 | 13.4 | 13.07 | 16.22 |
| Fortis Healthcare Ltd. | FORTIS | 55,553.6 | 52.45 | 5.41 | 11.32 | 14.07 |
| Narayana Hrudayalaya Ltd. | NH | 35,602.72 | 43.21 | 7.43 | 19.86 | 16.2 |
Max Healthcare Institute Ltd. (MAXHEALTH) has a P/E ratio of 54.78x compared with the displayed peer median of 52.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.53% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 14.97% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Max Healthcare Institute Ltd. (MAXHEALTH) has a market capitalisation of Rs 80,716.62 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching
- MAXHEALTH has traded within 2% of its 52-week low for a second straight session, making the repeated weak zone more important than a single-day move.
- The cumulative decline across the streak is 1.78%, which gives investors a clearer read on the price trend than the day’s change alone.
- The current P/E of 54.78 and P/B of 7.3 keep valuation in focus when comparing MAXHEALTH with hospital-sector peers.
- ROE of 14.53% and ROCE of 14.97% provide a fundamentals lens, especially when matched with peer metrics.
- The latest Univest data confirms the pattern but does not establish a company-specific cause, so readers are watching for fresh company news and market update signals.
About the Company
Max Healthcare Institute Ltd. operates in the Hospital & Healthcare Services industry within the Healthcare sector. The company has a market capitalisation of Rs 80,716.62 crore and is one of the more closely tracked healthcare names in the listed space. Investors follow the stock for its earnings profile, valuation trends and position within a competitive sector that includes several large hospital operators.
As a listed healthcare company, MAXHEALTH is often discussed in the context of market cap, profitability metrics and comparative valuation rather than just day-to-day share price movement. That is why the current MAXHEALTH share price pattern matters: the stock is not only near its 52-week low, but also trading in a range that invites deeper stock analysis rather than a purely short-term reading. The MAXHEALTH 52 Week Low Streak remains the central lens for readers tracking this stock news item.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What does MAXHEALTH 52 Week Low Streak mean?
Ans. It means Max Healthcare Institute Ltd. has traded within 2% of its 52-week low for consecutive sessions. In this case, the streak has reached a second straight session, showing repeated trading near the yearly low.
How many sessions has MAXHEALTH stayed near its 52-week low?
Ans. MAXHEALTH has stayed within 2% of its 52-week low for a second straight session. That repeated pattern is more important than a single-day dip because it shows continued weakness over multiple trading sessions.
Did MAXHEALTH set a new 52-week low today?
Ans. The available data shows the stock traded near its 52-week low, but it does not say that a new 52-week low was set today. The focus is on the repeated trading close to that level.
Is a company-specific reason confirmed for the repeated weakness?
Ans. No company-specific cause is confirmed by the latest data. The pattern is clear, but the information provided does not identify a direct business or event-driven reason for the continued move.
How does MAXHEALTH look on valuation versus peers?
Ans. MAXHEALTH trades at a P/E of 54.78 and a P/B of 7.3, both above the industry median. Compared with peers, the stock still looks on the richer side of the healthcare valuation range.
What fundamentals should investors watch in MAXHEALTH stock news?
Ans. Investors can track earnings growth, ROE, ROCE, book value and valuation multiples. These measures help place the share price trend in a broader fundamental context rather than focusing only on the daily move.
Why is the MAXHEALTH share price near its yearly low important?
Ans. A repeated move near the yearly low can change how the market reads the stock. It highlights caution around the MAXHEALTH share price and shifts attention toward valuation, sector context and future company news.
Track Max Healthcare Institute Ltd. (MAXHEALTH) Share Price on Univest
Use Max Healthcare Institute Ltd. (MAXHEALTH) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.